ClearPoint Neuro Inc. has entered into a new agreement with CALW SA LLC, as purchaser agent, and TPC Investments III LP, an affiliate of Oberland Capital Management LLC, amending an existing Note Purchase Agreement. Under the amendment and related consent, ClearPoint Neuro will complete an internal reorganization of its Swedish subsidiary, IRRAS AB, by January 15, 2026, including transferring equity interests in IRRAS USA, Inc. to ClearPoint or its direct U.S. subsidiary. This reorganization will help IRRAS AB qualify as an "Immaterial Foreign Subsidiary" under the terms of the agreement. The amendment follows a previous arrangement for the investor to purchase $20 million in notes after ClearPoint’s acquisition of IRRAS Holdings, Inc. The material economic terms of the original Note Purchase Agreement remain unchanged.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ClearPoint Neuro Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-001581), on January 05, 2026, and is solely responsible for the information contained therein.